Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MIG | 17.0 | 58 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | MIG | 17.0 | 55 | |
RA2159 | Sigma A6730 | 3.0 | uM | 1 | MIG | 20.0 | 58 | ||||
N2586 | IL-6 | 100 | ug/mL | 1 | MIG | 48.5 | 70 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | MIG | 44.0 | 68 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MIG | 36.0 | 63 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MIG | 45.0 | 47 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MIG | 35.0 | 55 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | MIG | 47.0 | 44 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | MIG | 56.0 | 53 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | MIG | 16.0 | 50 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | MIG | 19.0 | 70 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | MIG | 18.0 | 62 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | MIG | 18.0 | 69 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | MIG | 20.0 | 56 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | MIG | 18.0 | 68 | |
N2586 | IL-17A | 100 | ng/mL | 1 | MIG | 70.0 | 37 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | MIG | 57.0 | 30 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | MIG | 52.0 | 30 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | MIG | 59.0 | 46 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | MIG | 48.0 | 43 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | MIG | 46.5 | 64 | |
RA2159 | 1 | MIG | 18.0 | 52 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | MIG | 23.0 | 75 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | MIG | 15.0 | 76 |